论文部分内容阅读
我院在１９５２～１９９７年共治疗甲状腺癌２０９７例，其中乳头状腺癌１７３２例１９５４～１９９２年间乳头状腺癌１２１９例，男３１７，女９０２例，男女之比为１：２．８５．年龄最小６岁，最大８０岁，中位年龄３７．６８岁，Ｓ＝１２．７２，行颈淋巴结清除术９１３例（７１例行双颈清除术），共９８４例次。通过对９１３例（９８４例次）颈淋巴结清除术的分析及随访。预防性组淋巴结阳性率为６６．３２％，治疗性组为９３．９８％，预防性组１０年以上无瘤生存率远高于治疗性组。治疗性组５年、１０年无瘤生存率功能性组优于传统性组（Ｐ＜０．０１），预防性组１０、１５、２０年无瘤生存率功能性组优于传统性组（Ｐ＜０．００５），说明功能性颈淋巴结清除术即保留功能又不降低生存率，是一种值得提倡的治疗方法。另外通过１０９例死亡原因回顾，死于复发和转移６２例（５６．８８％），术后１０年内死亡者占８３．８７％（５２／６２），术后１０年以上复发机会明显减少。转移瘤多以肺转移为主，占７１．４％。
In our hospital from 1952 to 1997, a total of 2097 cases of thyroid cancer were treated, of which 1732 cases of papillary adenocarcinoma were papillary adenocarcinomas (1219 cases) from 1954 to 1992. There were 317 males and 902 females. The ratio between male and female was 1:2.85. The youngest was 6 years old, and the oldest was 80 years old. The median age was 37.68 years old and S=12.72. There were 913 cases of neck lymphadenectomy (71 cases of double neck removal), a total of 984 cases. Through 913 cases (984 cases) cervical lymph node dissection analysis and follow-up. The positive rate of the prophylactic group was 66.32%, and the therapeutic group was 93.98%. The prophylactic group had more than 10 years of disease-free survival rate than the therapeutic group. The 5-year and 10-year disease-free survival rate in the therapeutic group was superior to that in the traditional group (P<0.01), and the 10-year, 15-year, and 20-year disease-free survival rates in the preventive group were superior to those in the traditional group ( P<0.005), indicating that functional cervical lymph node dissection retains function without reducing survival rate, is a treatment method worthy of promotion. In addition, through the review of 109 causes of death, 62 patients (56.88%) died of recurrence and metastasis, and 83.87% (52/62) died within 10 years after surgery. The chance of recurrence after 10 years is significantly reduced. Metastatic tumors were mostly lung metastases, accounting for 71.4%.